UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report: February 8, 2012
(Date
of earliest event reported):
INNODATA
ISOGEN, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
0-22196 |
13-3475943 |
(State or other jurisdiction of incorporation) |
(Commission File Number)
|
(I.R.S. Employer Identification No.) |
Three University Plaza Hackensack, NJ 07601 |
07601 |
|
(Address of principal executive offices) |
(Zip Code) |
(201)
371-8000
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On February 8, 2012, Innodata Isogen, Inc. issued a press release announcing its fourth quarter and year end 2011 financial results. A copy of the press release is attached hereto as Exhibit 99.1.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
99.1 Press release dated February 8, 2012.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INNODATA ISOGEN, INC. |
|||
|
|||
Date: | February 8, 2012 | By: |
/s/ O’Neil Nalavadi |
O’Neil Nalavadi |
|||
Senior Vice President and Chief Financial Officer |
INDEX
TO EXHIBITS
Exhibit No. |
Description |
||
99.1 |
Press Release of Innodata Isogen, Inc., dated February 8, 2012, reporting fourth quarter and year end 2011 financial results. |
4